Evaluation of the impact of SEXIT game as an educational intervention on sexual health and the prevention, diagnosis, and treatment of sexually transmitted infection

Evaluation of the impact of an online video game as an educational intervention on sexual health and the prevention, diagnosis, and treatment of sexually transmitted infection: a randomized controlled trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN17783607

Enrollment

300

Registered

2024-03-08

Start date

2023-11-01

Completion date

Unknown

Last updated

2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medical training, sexual health and the prevention, diagnosis, and treatment of sexually transmitted infections Infections and Infestations

Interventions

The researchers will design, develop, and evaluate an educational intervention in the form of a video game aimed at primary care professionals. The intervention will be studied and compared with contr

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Family and community medicine and nursing residents 2. Family doctors and primary care nurses with assigned quotas

Exclusion criteria

Exclusion criteria: 1. Not having devices to play the game online 2. Impossibility of carrying out the follow-up after 6 months 3. Referent in sexually transmitted infections professionals

Design outcomes

Primary

Measure	Time frame
The impact of the intervention will be assessed at three levels, following Kirkpatrick’s model: reaction, learning, and clinical behaviour change: 1. Reaction: measured by a qualitative survey after the intervention after the intervention 2. Learning: measured by a self-developed questionnaire (score over 25) at baseline, after the intervention, and 3 months later. 3. Evaluation of changes in the application of the knowledge acquired in clinical practice: 3.1. STI tests realized during the study period (6 months) 3.2. Prevalence of STI registered during the study period (6 months) 3.2.1. Multitest urine PCR: Number of tests ordered during the study period (6 months) 3.2.2. Multitest urethral PCR: Number of tests ordered during the study period (6 months) 3.2.3. Multitest vaginal PCR: Number of tests ordered during the study period (6 months) 3.2.4. Multitest pharyngeal PCR: Number of tests ordered during the study period (6 months) 3.2.5. Multitest rectal PCR: Number of tests ordered during the study period (6 months) 3.2.6. Multitest ulcer PCR: Number of tests ordered during the study period (6 months) 3.2.7. Urethral swab cultures: Number of tests ordered during the study period (6 months) 3.2.8. Vaginal swab cultures: Number of tests ordered during the study period (6 months) 3.2.9. Pharyngeal swab cultures: Number of tests ordered during the study period (6 months) 3.2.10. Rectal swab cultures: Number of tests ordered during the study period (6 months) 3.2.11. HIV serologies: Number of tests ordered during the study period (6 months) 3.2.12. Hepatitis A serologies: Number of tests ordered during the study period (6 months) 3.2.13. Hepatitis B serologies: Number of tests ordered during the study period (6 months) 3.2.14. Hepatitis C serologies: Number of tests ordered during the study period (6 months) 3.2.15. Treponema pallidum serologies: Number of tests ordered during the study period (6 months) 3.3. ECAP registration of health problems with an aetiological or	—

Measure

Time frame

The impact of the intervention will be assessed at three levels, following Kirkpatrick’s model: reaction, learning, and clinical behaviour change: 1. Reaction: measured by a qualitative survey after the intervention after the intervention 2. Learning: measured by a self-developed questionnaire (score over 25) at baseline, after the intervention, and 3 months later. 3. Evaluation of changes in the application of the knowledge acquired in clinical practice: 3.1. STI tests realized during the study period (6 months) 3.2. Prevalence of STI registered during the study period (6 months) 3.2.1. Multitest urine PCR: Number of tests ordered during the study period (6 months) 3.2.2. Multitest urethral PCR: Number of tests ordered during the study period (6 months) 3.2.3. Multitest vaginal PCR: Number of tests ordered during the study period (6 months) 3.2.4. Multitest pharyngeal PCR: Number of tests ordered during the study period (6 months) 3.2.5. Multitest rectal PCR: Number of tests ordered during the study period (6 months) 3.2.6. Multitest ulcer PCR: Number of tests ordered during the study period (6 months) 3.2.7. Urethral swab cultures: Number of tests ordered during the study period (6 months) 3.2.8. Vaginal swab cultures: Number of tests ordered during the study period (6 months) 3.2.9. Pharyngeal swab cultures: Number of tests ordered during the study period (6 months) 3.2.10. Rectal swab cultures: Number of tests ordered during the study period (6 months) 3.2.11. HIV serologies: Number of tests ordered during the study period (6 months) 3.2.12. Hepatitis A serologies: Number of tests ordered during the study period (6 months) 3.2.13. Hepatitis B serologies: Number of tests ordered during the study period (6 months) 3.2.14. Hepatitis C serologies: Number of tests ordered during the study period (6 months) 3.2.15. Treponema pallidum serologies: Number of tests ordered during the study period (6 months) 3.3. ECAP registration of health problems with an aetiological or

—

Secondary

Measure	Time frame
Changes in clinical attitude measured by the response to the extra question (26) in the knowledge test at baseline, post-intervention, 3 months	—

Countries

Spain

Contacts

Public ContactAlba Martinez Satorres

amartinezsat.bcn.ics@gencat.cat+34 (0)678658229

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 6, 2026